Before the plan adds more, a clinic should review the client’s existing supplement list as it is actually taken. The doctor then decides, product by product, whether to continue, adjust, pause or stop, and the client leaves with one approved regimen. The next review treats continuation as a decision.
Key takeaways
- A longevity clinic supplement review should happen before the plan adds more, not after a new stack has been written.
- Ask about supplements by name and record what the client actually takes, not what the label suggests, including whether products are stacked, combined or taken above the labelled dose.
- Give every existing product a current reason, then make an explicit doctor decision: continue, adjust, pause or stop.
- Look at the combined regimen once the plan’s own components are added, not each new item on its own, and give the client one approved list.
- To prepare for follow-up labs, record what the client took before a retest so the next panel can be read in context.
- At each review, continuing a product is a decision, not a default.
Why review a client’s supplement list before the plan adds more?
Because a plan that adds without reviewing can leave the client with more to take and less clarity about why. Many clients arrive with a self-directed regimen built from reading, podcasts and advice from friends. Some of it may fit the clinic’s approach. Some may duplicate what the plan is about to propose.
Two products can contain the same ingredient, so the total amount can be higher than either label suggests on its own. The NHS Specialist Pharmacy Service advises checking the total daily amount of each ingredient and considering possible interactions with conventional medicines.
For a longevity clinic, the existing regimen is information to inspect, in the same way an outside lab panel is. We covered that sibling problem in reviewing a consumer lab panel at intake.
How should a clinic record what a client already takes?
Ask by name, every time, and record the regimen as the client actually takes it. Clients do not always count supplements as medicine, so a general question about medication can miss them entirely.
The US Operation Supplement Safety (OPSS) guidelines suggest asking whether clients combine products to get a desired effect and whether they ever take more than the label recommends.
In UK practice this sits alongside medicines reconciliation: bringing the existing regimen, prescribed medicines and the doctor’s product-by-product decisions into one record the team can reuse at review.
A practical intake record for each product usually covers:
- The product name and form, as written on the packaging the client brings or photographs
- The amount the client actually takes, and how often
- When they started and why
- Where it came from, and who suggested it
- Whether it is combined with other products
What should the doctor ask about each product?
Each product needs a reason that still holds. IMED University’s guide for providers suggests asking whether a documented deficiency, a dietary restriction or a clinical goal prompted the client to start taking it. Ask whether that reason still applies and what has changed since they started.
In a longevity programme, the clinic’s own methodology adds a further test: does this product belong in the approach the clinic is about to agree with the client? A product the client started for a goal the clinic shares may fit. A product that overlaps with something the plan will propose may not need to continue alongside it.
Who decides when products combine?
The doctor does. Checking pairs is only the start. The NHS Specialist Pharmacy Service explains that published evidence usually covers a single ingredient alongside a single medicine. Assessing a regimen with several ingredients or medicines is likely to call for clinical judgement.
That is the reality of a self-directed regimen. The doctor reviews the supplement list alongside the medication list. Weighing several products, the client’s medicines and the clinic’s plan together is a clinical task.
What happens when the plan’s own components are added?
The question changes from “is this product reasonable?” to “is this whole regimen reasonable for this client?”. A plan might add nutrition, activity, sleep and supplement components. Each may be sensible alone. Together with what the client already takes, they can become a daily routine the client struggles to understand.
IMED’s guide suggests asking the client which parts of the plan are hardest to follow. Asking before approval, and again at review, keeps the regimen tied to what the client can realistically carry.
How should the doctor record the decision?
Make it explicit and give it a reason. For each existing product, the doctor decides to continue, adjust, pause or stop, and notes why. The plan’s new components are then reviewed alongside those decisions, not on top of them.
This is where a clear approval moment matters. The doctor reviews the proposed plan as a whole, amends it where needed and explicitly approves it before the client receives it. A recorded reason for each decision gives the next review something to work from.
What should the client receive afterwards?
One list, not two. The client should see the agreed regimen as a single set of daily actions, with frequency, short instructions and the reason for each, rather than the clinic’s plan sitting beside an old routine they are left to reconcile alone.
When the client has a question between visits, the answer should come from the approved plan. If the client wants to change something, that request should come back to the team for review, not be settled on the client’s own.
What should be recorded before the retest?
Record what the client actually took, and when, before the follow-up panel. Knowing which products the client started, stopped or adjusted, and whether they followed any pre-test instructions, can help the team interpret differences between panels. Some supplements can affect laboratory results; for example, a May 2023 UK healthcare professional letter highlighted that biotin can interfere with some thyroid function tests. (UK healthcare professional letter, May 2023) Any decision to pause a product before a draw belongs to the doctor or the laboratory.
Recording this alongside the follow-up panel means the doctor reads the new results against the regimen as it was, not as it was planned. It also helps the team notice when a product the client added on their own has entered the picture since the last review. For the wider handoff between tests, see our post on test-to-retest handoffs in longevity clinics.
Why should continuation be a decision at every review?
Because a product that earned its place at intake may not still earn it later. The client’s goals, results and medicines can change. At each review, the doctor looks again at every product on the regimen and decides whether it stays, with the earlier reasoning in view.
Where does HolistiCare fit?
HolistiCare is clinical decision support that works alongside your clinic’s existing EHR. It is not an EHR and does not replace the clinical record. AI organises and analyses information and proposes next steps; care-plan decisions stay with the doctor.
In HolistiCare, that review happens inside one doctor-led workflow: the client’s answers and records, a draft shaped by your methodology, the doctor’s amendments and approval, and the daily actions the client sees.
Here is how that supports a supplement review:
- Your own intake questions. Questionnaires can use templates or custom question sets, including your own, so the clinic can ask its supplement-history questions its way.
- Source context for the next panel. Supported inputs come together in a connected client view, with provenance and data-quality flags to support review. Normalisation includes unit conversion where appropriate and reference-range context such as age and sex.
- A draft shaped by your methodology. HolistiCare drafts a plan across nutrition, supplements, activity, sleep and lifestyle, aligned with the clinic’s configured methodology. The doctor reviews the supplement list alongside the medication list.
- The doctor decides. The doctor can edit proposed interventions, review rationale, set goals and explicitly approve the plan. Each new or changed care plan needs explicit doctor approval before it reaches the client. The proposal reflects your clinic’s configured methodology, and the doctor’s amendments and approval are recorded in the plan’s version history.
- The approved plan, as daily actions. Approved plans become daily tasks that can carry frequency, short instructions and rationale, with reminders that reinforce the approved plan. Patient AI Chat retrieves and explains the doctor-approved plan; it does not create a new one.
- A route back. Clients can report barriers and request adjustments. Requests are reviewed and recorded, and any resulting plan change needs doctor approval. Version history records how the plan evolves.
Some team capabilities depend on the plan. Clinic-level plan templates, team task routing and the follow-up lab order workflow are part of Clinic and Enterprise. Doctor plan approval is included in every plan.
Frequently asked questions
How many supplements is too much?
There is no universal number of supplements that is too much for every patient. The useful question is whether each product has a current reason, how it overlaps with the rest of the regimen and the clinic’s plan, and whether the client can follow the whole routine. That judgement belongs to the doctor for each client.
How often should a clinic review a client’s supplements?
A clinic should review a client’s supplements at intake, whenever the client’s medicines change and at each clinical review. We would not set a fixed interval: the clinic’s own methodology and the doctor decide what fits the programme.
Should clients stop supplements before a blood test?
Clients should follow the instructions of their laboratory or doctor. Whatever the instruction, the clinic should record what the client actually took before the draw so the results can be read in context.
Should a clinic ask about every supplement a client takes?
Yes. Ask about each product by name, including powders, gummies and occasional products that a general medication question can miss. Record the regimen as it is actually taken, so the doctor can review each product before the plan adds more.
Your care, carried through.
Bring one of your own intake workflows
Choose one representative intake with a supplement-heavy regimen, using synthetic details only, and see how it moves from the client’s existing products to a doctor-approved plan and the client’s daily list. Keep patient and member information out of the booking. Share your EHR name so the technical team can assess the relevant connection.
Sources and scope
- US Department of Defense Operation Supplement Safety (OPSS), Guidelines for taking a comprehensive dietary supplement history, updated 18 September 2017.
- IMED University, 28 October 2026, a US provider-education site.
- NHS Specialist Pharmacy Service, Managing complementary products and conventional medicines, updated 16 July 2026.
- UK healthcare professional letter on biotin interference with laboratory tests, May 2023. NICE’s October 2023 exceptional surveillance of guideline NG145 also discusses biotin interference with thyroid function tests.
This piece is a discussion aid for longevity clinic teams. It is not clinical advice to consumers and it does not set a clinic’s methodology, intervals or testing rules. It does not tell clients to start or stop any product on their own. Medicines reconciliation is used here as a description of the clinical task, not as a claim about any particular software feature.